EnteroBiotix

About:

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.

Website: http://enterobiotix.com/

Twitter/X: enterobiotix

Top Investors: Scottish Enterprise, University of Aberdeen, Fund Twenty8, Scottish National Investment Bank, SIS Ventures

Description:

EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome-modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in the human gut, enabling physicians to prevent and treat debilitating infections and diseases.

Total Funding Amount:

$53.8M

Headquarters Location:

Edinburgh, Edinburgh, City of, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)enterobiotix.com

Founders:

James McIlroy

Number of Employees:

11-50

Last Funding Date:

2024-04-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai